Fair Value (Details Textual) |
6 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
|
Jul. 07, 2020
USD ($)
|
Apr. 08, 2020
USD ($)
|
Jan. 15, 2020
USD ($)
|
Dec. 31, 2020
CAD ($)
|
Dec. 31, 2020
USD ($)
|
Jun. 30, 2020
USD ($)
|
Dec. 31, 2020
USD ($)
|
Jun. 09, 2020
USD ($)
|
|
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||
| Principal amount | $ 17,000,000 | |||||||
| Purchase price | $ 15,000,000 | |||||||
| Settled value of the contingent consideration | ||||||||
| Gain on settlement of the contingent consideration liability | 998,000 | |||||||
| Trellis Solutions, Inc [Member] | ||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||
| Fair value of the contingent consideration | $ 0 | $ 998,000 | ||||||
| Settled value of the contingent consideration | $ 3,529 | |||||||
| Solo Sciences, Inc. [Member] | ||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||
| Description of contingent consideration | (i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029. | (i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029. | ||||||
| Fair value of the contingent consideration | 389,000 | |||||||
| Settled value of the contingent consideration | $ 17,939 | $ 0 | ||||||
| Gain on settlement of the contingent consideration liability | $ 389,000 | |||||||
| Ample Organics [Member] | ||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||
| Description of contingent consideration | The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000and the amount of Recurring Revenue realized during the twelve months following the acquisition. | The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000and the amount of Recurring Revenue realized during the twelve months following the acquisition. | ||||||
| Fair value of the contingent consideration | $ 10,000,000 | $ 604,000 | ||||||
| Settled value of the contingent consideration | $ 31,531 | $ 0 | ||||||
| Gain on settlement of the contingent consideration liability | $ 604,000 | |||||||
| Recurring revenue recognized | $ 9,000,000 | |||||||